LLY

915.12

+1.67%↑

JNJ

240.83

+2.83%↑

ABBV

207.28

+1.45%↑

NVS

151.34

+2.08%↑

AZN

188.36

+2%↑

LLY

915.12

+1.67%↑

JNJ

240.83

+2.83%↑

ABBV

207.28

+1.45%↑

NVS

151.34

+2.08%↑

AZN

188.36

+2%↑

LLY

915.12

+1.67%↑

JNJ

240.83

+2.83%↑

ABBV

207.28

+1.45%↑

NVS

151.34

+2.08%↑

AZN

188.36

+2%↑

LLY

915.12

+1.67%↑

JNJ

240.83

+2.83%↑

ABBV

207.28

+1.45%↑

NVS

151.34

+2.08%↑

AZN

188.36

+2%↑

LLY

915.12

+1.67%↑

JNJ

240.83

+2.83%↑

ABBV

207.28

+1.45%↑

NVS

151.34

+2.08%↑

AZN

188.36

+2%↑

Strona główna・Stock List・Cassava Sciences Inc

Cassava Sciences Inc

Open

SectorHealthcare

2.1 -0.94

Buy Sell

Overview

Share price change

24h

Current

Min

2.1

Max

2.1

Key metrics
By Trading Economics
Income	-1.7M -13M
Sales	840K 840K
Profit margin	-1,492.738
Employees	30
EBITDA	-39M -50M

Market Stats
By TradingEconomics
Market Cap	-4.3M 142M
Previous open	3.04
Previous close	2.1

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

1.56 / 1.7 Support & Resistance

Cassava Sciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 mar 2026, 18:34 UTC

Earnings

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

19 mar 2026, 17:43 UTC

Major Market Movers

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

19 mar 2026, 23:39 UTC

Earnings

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

19 mar 2026, 23:39 UTC

Earnings

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

19 mar 2026, 23:39 UTC

Earnings

Li Ning: Outdoor Category Continued Growing >2331.HK

19 mar 2026, 23:38 UTC

Earnings

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

19 mar 2026, 23:33 UTC

Market Talk

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

McCormick Has a Market Value of Around $14.8B -- WSJ

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

19 mar 2026, 22:23 UTC

Market Talk

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

19 mar 2026, 22:09 UTC

Market Talk

Major News Events

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

19 mar 2026, 22:06 UTC

Market Talk

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

19 mar 2026, 22:04 UTC

Earnings

Acquisitions, Mergers, Takeovers

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

19 mar 2026, 22:03 UTC

Market Talk

Major News Events

Global Energy Roundup: Market Talk

19 mar 2026, 22:03 UTC

Market Talk

Major News Events

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

19 mar 2026, 21:51 UTC

Earnings

Acquisitions, Mergers, Takeovers

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

19 mar 2026, 20:57 UTC

Major News Events

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

19 mar 2026, 20:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

19 mar 2026, 20:19 UTC

Major News Events

Brent Crude Retreats After Touching $119 -- WSJ

19 mar 2026, 19:49 UTC

Market Talk

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

19 mar 2026, 19:26 UTC

Major News Events

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

19 mar 2026, 19:10 UTC

Market Talk

Major News Events

Natural Gas Rises in Volatile Trading -- Market Talk

19 mar 2026, 19:06 UTC

Major News Events

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

19 mar 2026, 18:08 UTC

Market Talk

Major News Events

Silver Extends Slide to Seven Straight Sessions -- Market Talk

Peer Comparison

Price change

Cassava Sciences Inc Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Cassava Sciences Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.56 / 1.7Support & Resistance

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

About Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.